ArticleBMC musculoskeletal disorders2013
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry.
Marloes Vermeer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled ittrialcites it